Osteoporosis: Background and Overview

Journal for Nurse Practitioners

Volumn 5, Issue 6 SUPPL. 1, 2009, Pages

  Knudtson, Mary ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66349119513     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2009.03.014     Document Type: Article

References (39)

1. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org/professionals/Clinicians_Guide.htm Accessed January 12, 2009.
2. Burge R., Dawson-Hughes B., Solomon D.H., et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22 3 (2007) 465-475
3. Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online 17 1 (2000 March 27-29) 1-36 Accessed June 26, 2008.
4. American Heart Association. Heart disease and stroke statistics - 2007 update (2007), American Heart Association, Dallas, TX
5. American Cancer Society. Cancer facts and figures 2005 (2005), American Cancer Society, Atlanta, GA
6. Cummings S.R., and Melton L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359 9319 (2002) 1761-1767
7. Winner S.J., Morgan C.A., and Evans J.G. Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ 298 6686 (1989) 1486-1488
8. Cooper C., and Melton L.J. Epidemiology of osteoporosis. Trends Endocrinol Metab 3 6 (1992) 224-229
9. Braithwaite R.S., Col N.F., and Wong J.B. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51 3 (2003) 364-370
10. Khosla S., and Riggs B.L. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 34 4 (2005) 1015-1030 xi.
11. Mundy G.R. Structure and physiology of the normal skeleton. In: Rubens R.D., and Mundy G.R. (Eds). Cancer and the skeleton (2000), Martin Dunitz Ltd, London 2
12. Gehlbach S.H., Fournier M., and Bigelow C. Recognition of osteoporosis by primary care physicians. Am J Public Health 92 2 (2002) 271-273
13. Gehlbach S.H., Bigelow C., Heimisdottir M., et al. Recognition of vertebral fracture in a clinical setting. Osteoporos Int 11 7 (2000) 577-582
14. Majumdar S.R., Kim N., Colman I., et al. Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165 8 (2005) 905-909
15. Delmas P.D., van de Langerijt L., Watts N.B., et al. Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT Study. J Bone Miner Res 20 4 (2005) 557-563
16. Hasserius R., Karlsson M.K., Nilsson B.E., Redlund-Johnell I., and Johnell O. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int 14 1 (2003) 61-68
17. Lindsay R., Silverman S.L., Cooper C., et al. Risk of new vertebral fracture in the year following a fracture. JAMA 285 3 (2001) 320-323
18. Roux C., Fechtenbaum J., Kolta S., Briot K., and Girard M. Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int 18 12 (2007) 1617-1624
19. Cockerill W., Lunt M., Silman A.J., et al. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 15 2 (2004) 113-119
20. Oglesby A.K., Minshall M.E., Shen W., Xie S., and Silverman S.L. The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women. J Rheumatol 30 7 (2003) 1579-1583
21. Salaffi F., Cimmino M.A., Malavolta N., et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34 7 (2007) 1551-1560
22. Johnell O., and Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17 12 (2006) 1726-1733
23. Boonen S., and Singer A.J. Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture. Curr Med Res Opin 24 6 (2008) 1781-1788
24. National Osteoporosis Foundation (NOF). Fast facts on osteoporosis. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm Accessed September 30, 2008.
25. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 6 (2005) 581-589
26. Kanis J.A., Johansson H., Johnell O., et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 16 7 (2005) 737-742
27. Kanis J.A., Johnell O., Oden A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 16 2 (2005) 155-162
28. van Staa T.P. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79 3 (2006) 129-137
29. Kanis J.A., Johansson H., Oden A., et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 6 (2004) 893-899
30. van Staa T.P., Leufkens H.G.M., Abenhaim L., Zhang B., and Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15 (2000) 993-1000
31. Ensrud K.E., Blackwell T., Mangione C.M., et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163 8 (2003) 949-957
32. Sornay-Rendu E., Munoz F., Garnero P., Duboeuf F., and Delmas P.D. Identification of osteopenic women at high risk of fracture: the OFELY Study. J Bone Miner Res 20 10 (2005) 1813-1819
33. De Laet C., Kanis J.A., Oden A., et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16 11 (2005) 1330-1338
34. Siris E.S., Chen Y.T., Abbott T.A., et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164 10 (2004) 1108-1112
35. Melton III L.J., Kan S.H., Wahner H.W., and Riggs B.L. Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age. J Clin Epidemiol 41 10 (1988) 985-994
36. ISCD Official Positions. Available at: http://www.iscd.org/Visitors/positions/OfficialPositionsText.cfm Accessed January 12, 2009.
37. Tosteson A., Melton L., Dawson-Hughes B., et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19 4 (2008) 437-447
38. Dawson-Hughes B., Tosteson A., Melton L., et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19 4 (2008) 449-458
39. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary. Osteoporos Int 8 Suppl 4 (1998) S3-S6